PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
21-Jan-2021 Sprint #4 Workshop: Bridging the silos between Clinical Research, eHealth & Digital Therapeutics - “The rise of patient-centric applications” Innovation Sprint
17-Jan-2021 Registration Opens for SMi’s 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference (HPAPi) SMi Group
14-Jan-2021 Registration Opens for SMi’s 21st Annual Pain Therapeutics Virtual Conference SMi Group
11-Jan-2021 Darren Green, GSK, conference chair invites you to attend AI in Drug Discovery Virtual Conference SMi Group
07-Jan-2021 Rinri Therapeutics Appoints Terri Gaskell, PhD as Chief Technology Officer Rinri Therapeutics
07-Jan-2021 Global Closed MRI Systems Market Comprehensive Study Explores Huge Growth in Future | Healthcare Industry | GE Healthcare, Philips Healthcare, Siemens Healthcare Marketresearch.biz
06-Jan-2021 New Executive Board Role at Synergy Vision as Growth Drives Transition from Small to Medium-Sized Enterprise Synergy Vision
04-Jan-2021 Stefan Przyborski from University of Durham invites you to join 3D Cell Culture Virtual Conference SMi Group
23-Dec-2020 MaxCyte to exceed 2020 Full Year market expectations MaxCyte
23-Dec-2020 Amryt Granted Orphan Drug Designation by the FDA for AP103 Amryt
23-Dec-2020 Novadip Biosciences Receives Rare Paediatric Disease Priority Review and Orphan Disease Designation Novadip Biosciences
23-Dec-2020 CURRANZ AWARDED TWO ACCOLADES AT THE EUROPEAN SPECIALIST SPORTS NUTRITION ALLIANCE AWARDS 2020 CurraNZ
23-Dec-2020 UPM Biochemicals grows lignin business with new Domtar supply agreement UPM Biochemicals
22-Dec-2020 VFMCRP and ChemoCentryx provide topline results from ACCOLADE trial of avacopan in C3 glomerulopathy including improved estimated glomerular filtration rate (eGFR) Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
22-Dec-2020 Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study Bone Therapeutics
22-Dec-2020 Chi-Med to Present at the 39th Annual JP Morgan Healthcare Conference Chi-Med
22-Dec-2020 Update on the recently acquired NTCD-M3 biotherapeutic clinical programme for prevention of recurrence of C. difficile infections Destiny Pharma plc
22-Dec-2020 GLOBAL TEAM OF SCIENTISTS UNITE TO ASSESS ROLE OF T CELLS IN THE BATTLE AGAINST COVID-19 AND EVALUATE STEPS IN MANAGING AND PROTECTING AGAINST FUTURE INFECTIOUS DISEASE Global T cell Expert Consortium
22-Dec-2020 54% of UK healthcare professionals say factors other than patients’ best interests influence their medical decision-making JMW’s Clinical Negligence team
22-Dec-2020 Polyphor receives approval to start first-in-human clinical trial of inhaled antibiotic murepavadin Polyphor